KX1-004

KX1-004 is an Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. KX1-004 has been used to protect the cochlea from hazardous noise.

Product information

CAS Number: 518058-84-9

Molecular Weight: 284.29

Formula: C16H13FN2O2

Synonym:

KX 1004

KX1004

KX1-004

Chemical Name: 5-fluoro-N-(3-hydroxybenzyl)-1H-indole-2-carboxamide.

Smiles: OC1=CC(CNC(=O)C2=CC3=CC(F)=CC=C3N2)=CC=C1

InChiKey: TUIHIKXCMCXXJG-UHFFFAOYSA-N

InChi: InChI=1S/C16H13FN2O2/c17-12-4-5-14-11(7-12)8-15(19-14)16(21)18-9-10-2-1-3-13(20)6-10/h1-8,19-20H,9H2,(H,18,21)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO: 57 mg/mL(200.49 mM).

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined.

HS Tariff Code: 382200

References:

1. Harris KC, et al. Hear Res. 2005, 208(1-2):14-25.

Products are for research use only. Not for human use.